| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.3 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.3 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |